文献速递心力衰竭与心肌病

微小RNA-21通过TGF-β1/Smad7通路促进慢性病毒性心肌炎小鼠心肌纤维化

[The effect of microRNA-21 on myocardial fibrosis in mice with chronic viral myocarditis].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2018-01-01

该研究将40只4周龄雄性Balb/c小鼠随机分为PBS组、CVMC组、CVMC+miR-21抑制剂组和CVMC+同型对照组,每组10只,研究总时间42天。结果显示miR-21抑制剂可改善CVMC小鼠心功能、减轻心肌纤维化,并下调心肌COL1-A1、COL3-A1 mRNA及TGF-β1蛋白表达、上调Smad7蛋白表达。结论提示miR-21通过TGF-β1/Smad7信号通路促进CVMC小鼠心肌纤维化。

要点

  • miR-21抑制剂可降低CVMC小鼠LVESD、LVEDD并提高LVEF。
  • miR-21抑制剂降低CVMC小鼠心肌CVF,但PS与对照组差异无统计学意义。
  • miR-21促进CVMC心肌纤维化可能通过TGF-β1/Smad7通路介导。

核心结论

  • miR-21可促进CVMC小鼠心肌纤维化,这一作用可能是通过TGF-β1/Smad7信号通路介导的。

研究设计与样本

  • 雄性4周龄Balb/c小鼠40只随机分为PBS组、CVMC组、CVMC+miR-21抑制剂组和CVMC+同型对照组,每组10只。
  • 首次注射CVB3液或PBS定为第0天,研究总时间为42天。
  • CVMC组、CVMC+miR-21抑制剂组和CVMC+同型对照组于第0、14和28天经腹腔注射100TCID50的CVB3液0.1、0.15和0.2 ml/只,PBS组同时点注射相同剂量PBS。
  • CVMC+miR-21抑制剂组和CVMC+同型对照组在第14和28天注射病毒液后分别经尾静脉注射miR-21抑制剂0.1 ml/只或同型对照0.1 ml/只。
  • 42天后行超声心动图评估心功能,取心脏行HE及Masson染色计算PS和CVF,RT-qPCR检测心肌miR-21、COL1-A1、COL3-A1 mRNA,Western blot检测TGF-β1和Smad7蛋白。

主要发现

  • CVMC组和CVMC+同型对照组LVESD、LVEDD均明显高于PBS组(P均<0.05),LVEF明显低于PBS组(P<0.05)。
  • CVMC+miR-21抑制剂组LVESD、LVEDD均低于CVMC组和CVMC+同型对照组(P均<0.05),LVEF明显高于CVMC组和CVMC+同型对照组(P均<0.05)。
  • CVMC组PS为(1.14±0.69)分、CVF为(17.86±2.61)%,CVMC+同型对照组PS为(1.00±0.63)分、CVF为(16.78±2.58)%,均明显高于PBS组[PS为0分,CVF为(5.70±1.42)%,P均<0.05]。
  • CVMC+miR-21抑制剂组CVF为(11.01±2.55)%,明显低于CVMC组和CVMC+同型对照组(P均<0.05);PS为(0.89±0.60)分,虽低于CVMC组和CVMC+同型对照组,但差异无统计学意义(P均>0.05)。
  • CVMC组和CVMC+同型对照组心肌miR-21、COL1-A1和COL3-A1 mRNA表达量均明显高于PBS组(P均<0.05),CVMC+miR-21抑制剂组上述指标均明显低于CVMC组和CVMC+同型对照组(P均<0.05);CVMC组和CVMC+同型对照组心肌TGF-β1蛋白表达量明显高于PBS组、Smad7蛋白表达量明显低于PBS组(P均<0.05),CVMC+miR-21抑制剂组TGF-β1蛋白表达量明显低于CVMC组和CVMC+同型对照组、Smad7蛋白表达量明显高于CVMC组和CVMC+同型对照组(P均<0.05)。

临床怎么用

  • 该研究为动物实验,提示miR-21抑制剂可能改善CVMC相关心功能不全并减轻心肌纤维化,但尚不能直接推导至临床患者。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the effect of microRNA-21 (miR-21) on myocardial fibrosis in mice with chronic viral myocarditis (CVMC) and related mechanisms. Methods: Forty 4-week-old Balb/c male mice were randomly divided into 4 groups (n=10 each): phosphate buffer saline (PBS) group, CVMC group, CVMC+miR-21 inhibitor group, CVMC+isotype control group. The first injection of Coxsackie virus B3 (CVB3) or PBS was performed on day 0, and the total study time was 42 days. Each mouse in CVMC group, CVMC+miR-21 inhibitor group and CVMC+isotype control group was intraperitoneally (i.p) injected with 100TCID50 CVB3 0.1, 0.15, and 0.2 ml on day 0, 14, and 28, respectively. The mice in PBS group were i.p injected with the same dose of PBS at the same time point. After the initial infection, each mouse in CVMC+miR-21 inhibitor group and CVMC+isotype control group was intravenously injected with 0.1 ml miR-21 inhibitor or 0.1 ml isotype control, on day 14 and 28. Cardiac function was measured on surviving mice of 4 groups by echocardiography on day 42. Then, the hearts were removed aseptically to observe the expressions of green fluorescence protein (GFP). The myocardial pathological changes were examined with HE, Masson staining and the myocardial pathological scores (PS), the collagen volume fraction (CVF) were calculated respectively. The levels of miR-21, collagen typeⅠ-A1 (COL1-A1) and collagen type Ⅲ-A1 (COL3-A1) mRNA in heart were detected by quantitative real-time polymerase chain reaction (RT-qPCR). Furthermore, the expressions of transforming growth factor-β1 (TGF-β1) and mothers against decapentaplegic homolog 7(Smad7) in heart were determined with Western blot assay. Results: (1) Cardiac function in 4 groups: Compared with PBS group, left ventricular end systolic diameter (LVESD) and left ventricular end diastolic diameter (LVEDD) were markedly increased in CVMC group and CVMC+isotype control group (all P<0.05), whereas the left ventricular ejection fraction (LVEF) was decreased (P<0.05). LVESD and LVEDD were significantly decreased, and LVEF was increased in CVMC+miR-21 inhibitor group compared with those in CVMC group and CVMC+isotype control group (all P<0.05). (2) Myocardial pathological changes: The expressions of GFP in CVMC+miR-21 inhibitor group and CVMC+isotype control group were visible in heart tissues frozen sections. The hearts in CVMC group and CVMC+isotype control group were enlarged and stiff, inflammatory cells were visible and significantly increased myocardial fibrosis was evidenced in mice of these two groups. Higher PS and CVF were evidenced in CVMC group (PS: 1.14±0.69 vs. 0, CVF: (17.86±2.61)% vs. (5.70±1.42)%, all P<0.05) and CVMC+isotype control group(PS: 1.00±0.63 vs. 0, CVF: (16.78±2.58)% vs. (5.70±1.42)%, all P<0.05) compared to PBS group. Compared with CVMC group and CVMC+isotype control group, degree of cardiac fibrosis was reduced in mice of CVMC+miR-21 inhibitor group (CVF: (11.01±2.55)% vs. (17.86±2.61)%, (11.01±2.55)% vs. (16.78±2.58)%, all P<0.05), whereas PS were similar between them (PS: 0.89±0.60 vs. 1.14±0.69, 0.89±0.60 vs. 1.00±0.63, all P>0.05). (3) Cardiac expressions of miR-21, COL1-A1 and COL3-A1 mRNA: The cardiac expressions of miR-21, COL1-A1 mRNA, COL3-A1mRNA in CVMC group and CVMC+isotype control group were markedly higher than those in PBS group (all P<0.05), which were significantly downregulated in CVMC+miR-21 inhibitor group (all P<0.05 vs. CVMC group and CVMC+isotype control group). (4) The cardiac expressions of TGF-β1 and Smad7 protein: The cardiac expressions of TGF-β1 protein in CVMC group and CVMC+isotype control group were markedly higher, whereas the cardiac Smad7 protein expressions were significantly lower (all P<0.05) than those in PBS group (all P<0.05), these changes could be reversed in CVMC+miR-21 inhibitor group (P<0.05 vs. CVMC group and CVMC+isotype control group). Conclusions: Our results suggest that miR-21 contributes to the myocardial fibrosis in CVMC mice through modulating TGF-β1/Smad7 signaling pathway. 目的: 研究微小RNA-21(miR-21)对小鼠慢性病毒性心肌炎(CVMC)心肌纤维化的影响及其可能机制。 方法: 雄性4周龄Balb/c小鼠40只按照随机数字表法分为磷酸盐缓冲液(PBS)组、CVMC组、CVMC+miR-21抑制剂组和CVMC+同型对照组,每组各10只。首次注射柯萨奇B3病毒(CVB3)液或PBS定为第0天,研究总时间为42 d。CVMC组、CVMC+miR-21抑制剂组和CVMC+同型对照组的小鼠均于第0、14和28天经腹腔注射100TCID50的CVB3液0.1、0.15和0.2 ml/只,同时点PBS组小鼠注射相同剂量的PBS。CVMC+miR-21抑制剂组和CVMC+同型对照组小鼠在第14和28天注射病毒液后分别经尾静脉注射miR-21抑制剂0.1 ml/只或同型对照0.1 ml/只。42 d后行超声心动图检查评估小鼠心功能,然后无菌留取小鼠心脏,观察心肌绿色荧光蛋白(GFP)的表达,同时行苏木素伊红及Masson染色观察心肌病理学特征,并计算心肌病理积分(PS)及胶原容积积分(CVF),实时荧光定量逆转录聚合酶链反应测定小鼠心肌中miR-21、Ⅰ型胶原(COL1-A1)及Ⅲ型胶原(COL3-A1)mRNA的表达,Western blot法测定心肌中转化生长因子-β1(TGF-β1)和母亲DPP同源物7(Smad7)蛋白的表达。 结果: (1)超声心动图检查结果:CVMC组和CVMC+同型对照组小鼠左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)均明显高于PBS组(P均<0.05),左心室射血分数(LVEF)明显低于PBS组(P<0.05)。CVMC+miR-21抑制剂组小鼠LVESD、LVEDD均低于CVMC组和CVMC+同型对照组(P均<0.05),LVEF明显高于CVMC组和CVMC+同型对照组(P均<0.05)。(2)心肌病理学检测结果:CVMC+miR-21抑制剂组和CVMC+同型对照组小鼠心肌切片在荧光显微镜下可见GFP表达。CVMC组和CVMC+同型对照组小鼠心脏肿大僵硬,镜下可见心肌散在坏死灶,周围少量炎性细胞浸润,间质成纤维细胞增生明显,胶原纤维堆积。CVMC组和CVMC+同型对照组小鼠心肌PS分别为(1.14±0.69)和(1.00±0.63)分,CVF分别为(17.86±2.61)%和(16.78±2.58)%,均明显高于PBS组[PS为0分,CVF为(5.70±1.42)%,P均<0.05]。CVMC+miR-21抑制剂组小鼠心肌周围少量炎性细胞浸润,间质纤维化的程度较轻,CVF为(11.01±2.55)%,明显低于CVMC组和CVMC+同型对照组(P均<0.05),PS为(0.89±0.60)分,虽低于CVMC组和CVMC+同型对照组,但差异无统计学意义(P均>0.05)。(3)心肌组织miR-21、COL1-A1和COL3-A1 mRNA的表达量:CVMC组和CVMC+同型对照组小鼠心肌组织中miR-21、COL1-A1和COL3-A1 mRNA的表达量均明显高于PBS组(P均<0.05),而CVMC+miR-21抑制剂组小鼠心肌中上述因子的mRNA表达量则均明显低于CVMC组和CVMC+同型对照组(P均<0.05)。(4)心肌组织TGF-β1和Smad7蛋白的表达量:CVMC组和CVMC+同型对照组小鼠心肌中TGF-β1蛋白表达量均明显高于PBS组,而Smad7蛋白表达量则均明显低于PBS组(P均<0.05)。CVMC+miR-21抑制剂组小鼠心肌中TGF-β1蛋白表达量明显低于CVMC组和CVMC+同型对照组,而Smad7蛋白表达量则明显高于CVMC组和CVMC+同型对照组(P均<0.05)。 结论: miR-21可促进CVMC小鼠心肌纤维化,这一作用可能是通过TGF-β1/Smad7信号通路介导的。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xue YM, Chen MG, Chen DW, et al. [The effect of microRNA-21 on myocardial fibrosis in mice with chronic viral myocarditis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 29925181. doi:10.3760/cma.j.issn.0253-3758.2018.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。